Constantijne H. Mom

2.2k total citations
57 papers, 1.1k citations indexed

About

Constantijne H. Mom is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Epidemiology. According to data from OpenAlex, Constantijne H. Mom has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Obstetrics and Gynecology, 25 papers in Reproductive Medicine and 24 papers in Epidemiology. Recurrent topics in Constantijne H. Mom's work include Endometrial and Cervical Cancer Treatments (36 papers), Cervical Cancer and HPV Research (23 papers) and Ovarian cancer diagnosis and treatment (20 papers). Constantijne H. Mom is often cited by papers focused on Endometrial and Cervical Cancer Treatments (36 papers), Cervical Cancer and HPV Research (23 papers) and Ovarian cancer diagnosis and treatment (20 papers). Constantijne H. Mom collaborates with scholars based in Netherlands, United States and Belgium. Constantijne H. Mom's co-authors include Elisabeth G.E. de Vries, Jourik A. Gietema, Pax H.B. Willemse, A.G.J. van der Zee, Jaap Verweij, Steven de Jong, Jacobus van der Velden, Evelien W. Duiker, Maaike A. van der Aa and A. Amelsberg and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Constantijne H. Mom

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Constantijne H. Mom Netherlands 17 425 397 285 230 221 57 1.1k
Marco Johannes Battista Germany 18 426 1.0× 245 0.6× 254 0.9× 203 0.9× 154 0.7× 76 998
Tomoka Ishibashi Japan 18 282 0.7× 447 1.1× 303 1.1× 410 1.8× 140 0.6× 80 1.1k
Gianni Amunni Italy 20 358 0.8× 261 0.7× 526 1.8× 449 2.0× 224 1.0× 55 1.2k
Yuko Sugiyama Japan 14 346 0.8× 244 0.6× 215 0.8× 142 0.6× 127 0.6× 62 968
Hidekatsu Nakai Japan 21 445 1.0× 323 0.8× 418 1.5× 667 2.9× 96 0.4× 75 1.3k
Étienne Buscail France 18 651 1.5× 336 0.8× 105 0.4× 164 0.7× 162 0.7× 55 1.3k
Vanda Salutari Italy 23 555 1.3× 333 0.8× 412 1.4× 722 3.1× 171 0.8× 110 1.5k
Toshiyuki Sumi Japan 17 200 0.5× 262 0.7× 168 0.6× 208 0.9× 88 0.4× 81 829
Maki Tanioka Japan 17 335 0.8× 261 0.7× 96 0.3× 91 0.4× 111 0.5× 76 841
Ida Paris Italy 16 370 0.9× 210 0.5× 98 0.3× 241 1.0× 189 0.9× 72 870

Countries citing papers authored by Constantijne H. Mom

Since Specialization
Citations

This map shows the geographic impact of Constantijne H. Mom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantijne H. Mom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantijne H. Mom more than expected).

Fields of papers citing papers by Constantijne H. Mom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constantijne H. Mom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantijne H. Mom. The network helps show where Constantijne H. Mom may publish in the future.

Co-authorship network of co-authors of Constantijne H. Mom

This figure shows the co-authorship network connecting the top 25 collaborators of Constantijne H. Mom. A scholar is included among the top collaborators of Constantijne H. Mom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constantijne H. Mom. Constantijne H. Mom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Groenendijk, Floris H., Gerrit K. Hooijer, Willemien J. van Driel, et al.. (2025). The prognostic potential of molecular subtypes including estrogen receptor status in endometrioid ovarian cancer. Gynecologic Oncology. 196. 137–145.
2.
Schaafsma, M. Ronald, Harold R Verhoeve, Petra L.M. Zusterzeel, et al.. (2025). The risk for residual AIS/CIN3+ after the first conservative surgical procedure for cervical adenocarcinoma in situ – A Dutch retrospective cohort study. Gynecologic Oncology. 200. 44–50.
4.
Wenzel, Hans H.B., Jacobus van der Velden, Anje M. Spijkerboer, et al.. (2024). Diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer — a nationwide Dutch cohort study. Insights into Imaging. 15(1). 36–36. 9 indexed citations
5.
Wenzel, Hans H.B., Marissa C. van Maaren, Jacobus van der Velden, et al.. (2024). Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study. Journal of Gynecologic Oncology. 36(2). e16–e16.
6.
Sistermans, Erik A., Hugo M. Horlings, Constantijne H. Mom, et al.. (2024). Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass. International Journal of Gynecological Cancer. 34(5). 713–721. 3 indexed citations
7.
Mom, Constantijne H., et al.. (2024). Recurrent cervical cancer detection using DNA methylation markers in self‐collected samples from home. International Journal of Cancer. 156(3). 659–667. 4 indexed citations
9.
Thijs, Anna M.J., Hans M. Westgeest, H.P.M. Smedts, et al.. (2023). Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol. Heliyon. 10(1). e23170–e23170. 2 indexed citations
10.
Verhoef, Viola M.J., Karolina Sikorska, Albert G. Siebers, et al.. (2023). Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study. The Lancet Oncology. 24(12). 1349–1358. 4 indexed citations
11.
12.
Heideman, Daniëlle A.M., Constantijne H. Mom, Chris J.L.M. Meijer, et al.. (2023). Methylation testing for the detection of recurrent cervical intraepithelial neoplasia. International Journal of Cancer. 153(12). 2011–2018. 6 indexed citations
13.
Yigit, Refika, et al.. (2023). The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter. Journal of Gynecologic Oncology. 34(6). e75–e75. 2 indexed citations
14.
Engelhardt, Ellen G., Mignon D J M van Gent, Constantijne H. Mom, et al.. (2022). Psychological impact of referral to an oncology hospital on patients with an ovarian mass. International Journal of Gynecological Cancer. 33(1). 74–82. 2 indexed citations
15.
Rotman, Jossie, A. Marijne Heeren, Sinéad M. Lougheed, et al.. (2020). Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma. Clinical Cancer Research. 26(14). 3791–3802. 21 indexed citations
16.
Velden, Jacobus van der, Constantijne H. Mom, Luc R.C.W. van Lonkhuijzen, et al.. (2019). Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy. International Journal of Gynecological Cancer. 29(5). 874–878. 16 indexed citations
17.
Ezendam, Nicole P. M., Florine A. Eggink, Dennis van Hamont, et al.. (2018). Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade. Gynecological Surgery. 15(1). 7–7. 5 indexed citations
18.
Rotman, Jossie, Constantijne H. Mom, Ekaterina S. Jordanova, Tanja D. de Gruijl, & Gemma G. Kenter. (2018). ‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment. BMC Cancer. 18(1). 888–888. 27 indexed citations
19.
Mom, Constantijne H., Jaap Verweij, Corina N.A.M. Oldenhuis, et al.. (2009). Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study. Clinical Cancer Research. 15(17). 5584–5590. 85 indexed citations
20.
Duiker, Evelien W., Constantijne H. Mom, Steven de Jong, et al.. (2006). The clinical trail of TRAIL. European Journal of Cancer. 42(14). 2233–2240. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026